Page last updated: 2024-10-18

racepinephrine and Hypersensitivity

racepinephrine has been researched along with Hypersensitivity in 1 studies

Racepinephrine: A racemic mixture of d-epinephrine and l-epinephrine.
4-[1-hydroxy-2-(methylamino)ethyl]benzene-1,2-diol : A catecholamine in which the aminoethyl side-chain is hydroxy-substituted at C-1 and methylated on nitrogen.

Hypersensitivity: Altered reactivity to an antigen, which can result in pathologic reactions upon subsequent exposure to that particular antigen.

Research Excerpts

ExcerptRelevanceReference
"In the treatment of acute bronchiolitis in infants, inhaled racemic adrenaline is not more effective than inhaled saline."2.78Racemic adrenaline and inhalation strategies in acute bronchiolitis. ( Brügmann-Pieper, SK; Brun, AC; Carlsen, KH; Engen, H; Eskedal, L; Haavaldsen, M; Hunderi, JO; Kvenshagen, B; Lunde, J; Lødrup Carlsen, KC; Mowinckel, P; Rolfsjord, LB; Siva, C; Skjerven, HO; Vikin, T, 2013)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Skjerven, HO1
Hunderi, JO1
Brügmann-Pieper, SK1
Brun, AC1
Engen, H1
Eskedal, L1
Haavaldsen, M1
Kvenshagen, B1
Lunde, J1
Rolfsjord, LB1
Siva, C1
Vikin, T1
Mowinckel, P1
Carlsen, KH1
Lødrup Carlsen, KC1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Bronchiolitis All-study, SE-Norway What is the Optimal Inhalation Treatment for Children 0-12 Months With Acute Bronchiolitis?[NCT00817466]Phase 4500 participants (Anticipated)Interventional2010-01-31Active, not recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trials

1 trial available for racepinephrine and Hypersensitivity

ArticleYear
Racemic adrenaline and inhalation strategies in acute bronchiolitis.
    The New England journal of medicine, 2013, Jun-13, Volume: 368, Issue:24

    Topics: Acute Disease; Administration, Inhalation; Age Factors; Bronchiolitis; Combined Modality Therapy; Do

2013